Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check3 days agoChange DetectedA new page revision tag v3.6.6 was added to the page metadata. The previous revision tag v3.6.5 was removed.SummaryDifference0.0%

- Check10 days agoChange DetectedA new NIH grant/contract identifier (2018) was added to the study's identifiers, representing funding information for the trial.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.6.5 has been added to the page. The Plain Language Summary section was removed and the Revision: v3.6.4 entry was deleted, affecting how the trial information is presented.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision metadata on the page was updated to v3.6.4, replacing the previous v3.6.3. This reflects a new release/version of the page's underlying software.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.2 on the page, indicating a minor page update.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, representing an administrative update to the page template. The study data and core information shown remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.